CYC682
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
FDA Pipeline Preview, August 2010 (Naproxcinod, Ticagrelor, Phenoxodiol, CBLB502, TOL101, Oral kinase inhibitor, GVAX CML vaccine, TXA127, Sapacitabine or CYC682, ICT-107, Perifosine or KRX-0401… Recent FDA action (through, July 2010) related to Naproxcinod, Ticagrelor, Phenoxodiol, CBLB502, TOL101, Oral kinase inhibitor…
volume 27 number 10 october 2009 nature biotechnology of infectious diseases and medicine development at GlaxoSmithKline’s…
2026 Background: CYC682 is converted by intestinal and plasma amidases to the active agent CNDAC [1-(2-C-cyano-2-deoxy-β -D…